For example, IL-6 may have some roles in the pathogenesis of MOG Ab demyelination and the anti-IL-6 pathway could be a promising target for new pharmacological treatments of steroid resistant MOG Ab associated demyelination, as has recently been shown in NMO [51]. The gene discussed is MOG; the disease is neuromyelitis optica.